secwatch.observer — SEC 8-K summary
======================================

Issuer:     CG Oncology, Inc. (CGON)
CIK:        0001991792
Form:       8-K
Filed at:   2026-06-08T20:02:15+00:00
Accession:  0001193125-26-261670
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

CG Oncology stockholders elect two Class II directors, ratify auditor at 2026 annual meeting
--------------------------------------------------------------------------------

- Christina Rossi elected with 67,531,501 shares for (99.87% of votes cast); Victor Tong Jr. elected with 62,401,874 shares for.
- Ernst & Young LLP ratified as independent auditor for FY2026 with 83,711,522 shares for (99.99% of votes cast).
- Say-on-pay approved on advisory basis with 65,894,959 shares for (97.6% of votes cast).
- Stockholders selected 1-year frequency for future advisory votes on executive compensation, with 66,962,791 shares for (99.2% of votes cast).
- Company will hold say-on-pay votes annually until next required frequency vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1991792/000119312526261670/0001193125-26-261670-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1991792/000119312526261670/d54487d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-261670

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer